Skip to Main Content

Author Details

Nicholas D Socci
1994
172
86
PMIDPaper TitleJournal TitlePublished Year
37163102A transposase-derived gene required for human brain development.bioRxiv2023
36355783Molecular Characterization of Acquired Resistance to KRASG12C-EGFR Inhibition in Colorectal Cancer.Cancer Discov2023
37943631PDGFRβ signaling cooperates with β-catenin to modulate c-Abl and biologic behavior of desmoid-type fibromatosis.2023
36780190Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy.Clin Cancer Res2023
36759711The endogenous repertoire harbors self-reactive CD4 T cell clones that adopt a follicular helper T cell-like phenotype at steady state.2023
37009699Moving Spatially Resolved Multiplexed Protein Profiling toward Clinical Oncology.Cancer Discov2023
36862133Overcoming Barriers to Tumor Genomic Profiling through Direct-to-Patient Outreach.Clin Cancer Res2023
37494469Tissue-specific features of the T cell repertoire after allogeneic hematopoietic cell transplantation in human and mouse.Sci Transl Med2023
34935874TCR signal strength defines distinct mechanisms of T cell dysfunction and cancer evasion.J Exp Med2022
35705560Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets.Nat Commun2022
35440124Genomic and transcriptomic analysis of a library of small cell lung cancer patient-derived xenografts.Nat Commun2022
36323682FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation.Nat Commun2022
35978189Ordered and deterministic cancer genome evolution after p53 loss.Nature2022
36505421Increased tumor glycolysis is associated with decreased immune infiltration across human solid tumors.2022
36564410Author Correction: FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation.Nat Commun2022
34847567An autoimmune stem-like CD8 T cell population drives type 1 diabetes.Nature2022
35013003Tumor MHC Class I Expression Associates with Intralesional IL2 Response in Melanoma.Cancer Immunol Res2022
33323400The Genetic Evolution of Treatment-Resistant Cutaneous, Acral, and Uveal Melanomas.Clin Cancer Res2021
34059130Tumor fraction-guided cell-free DNA profiling in metastatic solid tumor patients.Genome Med2021
34103301Recurrent Mutations in Cyclin D3 Confer Clinical Resistance to FLT3 Inhibitors in Acute Myeloid Leukemia.Clin Cancer Res2021
33123756Impact of tumor heterogeneity and microenvironment in identifying neoantigens in a patient with ovarian cancer.Cancer Immunology, Immunotherapy2021
32918070Author Correction: PGBD5 promotes site-specific oncogenic mutations in human tumors.Nat Genet2020
32193223The Evolutionary Origins of Recurrent Pancreatic Cancer.Cancer Discov2020
32284593Eomes identifies thymic precursors of self-specific memory-phenotype CD8 T cells.Nature Immunology2020
32161142Rb and p53-Deficient Myxofibrosarcoma and Undifferentiated Pleomorphic Sarcoma Require Skp2 for Survival.Cancer Res2020
30943409PI3K Inhibition Activates SGK1 via a Feedback Loop to Promote Chromatin-Based Regulation of ER-Dependent Gene Expression.Cell Rep2019
31692889Extramammary Paget disease shows differential expression of B7 family members B7-H3, B7-H4, PD-L1, PD-L2 and cancer/testis antigens NY-ESO-1 and MAGE-A.Oncotarget2019
30589920Analysis of the Prevalence of Microsatellite Instability in Prostate Cancer and Response to Immune Checkpoint Blockade.JAMA Oncol2019
31237614Genomic and Transcriptomic Characterization of Papillary Microcarcinomas With Lateral Neck Lymph Node Metastases.J Clin Endocrinol Metab2019
30842593Author Correction: The Rho GTPase Rnd1 suppresses mammary tumorigenesis and EMT by restraining Ras-MAPK signalling.Nat Cell Biol2019
29066084Comparative Genomic Profiling of Matched Primary and Metastatic Tumors in Renal Cell Carcinoma.Eur Urol Focus2018
29990309Hgf/Met activation mediates resistance to BRAF inhibition in murine anaplastic thyroid cancers.Journal of Clinical Investigation2018
29760048Tipifarnib Inhibits HRAS-Driven Dedifferentiated Thyroid Cancers.Cancer Res2018
29180607Small-Cell Carcinomas of the Bladder and Lung Are Characterized by a Convergent but Distinct Pathogenesis.Clin Cancer Res2018
29337640Molecular Determinants of Response to Anti-Programmed Cell Death (PD)-1 and Anti-Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non-Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing.J Clin Oncol2018
29247016Accelerating Discovery of Functional Mutant Alleles in Cancer.Cancer Discov2018
27751729Genomic Biomarkers of a Randomized Trial Comparing First-line Everolimus and Sunitinib in Patients with Metastatic Renal Cell Carcinoma.Eur Urol2017
28504702PGBD5 promotes site-specific oncogenic mutations in human tumors.Nat Genet2017
28951624Erratum: PGBD5 promotes site-specific oncogenic mutations in human tumors.Nat Genet2017
28882999miR-193b-Regulated Signaling Networks Serve as Tumor Suppressors in Liposarcoma and Promote Adipogenesis in Adipose-Derived Stem Cells.Cancer Res2017
28606718Abdominal imaging post bariatric surgery: predictors, usage and utility.2017
27491780Forward genetic screen of human transposase genomic rearrangements.BMC Genomics2016
26960398Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma-like and Non-Small Cell Carcinoma-like Subsets.Clin Cancer Res2016
27130899Aire Enforces Immune Tolerance by Directing Autoreactive T Cells into the Regulatory T Cell Lineage.Immunity2016
27037189Dendritic Cells Coordinate the Development and Homeostasis of Organ-Specific Regulatory T Cells.Immunity2016
26992943Genetic analysis of five children with essential thrombocytosis identified mutations in cancer-associated genes with roles in transcriptional regulation.Haematologica2016
27119120Molecular network, pathway, and functional analysis of time-dependent gene changes associated with pancreatic cancer susceptibility to oncolytic vaccinia virotherapy.Molecular Therapy - Oncolytics2016
26619011Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.Nat Biotechnol2016
27577794Integrin-α10 Dependency Identifies RAC and RICTOR as Therapeutic Targets in High-Grade Myxofibrosarcoma.Cancer Discov2016
27702896Mutational landscape of EGFR-, MYC-, and Kras-driven genetically engineered mouse models of lung adenocarcinoma.Proc Natl Acad Sci U S A2016
  • 1 - 50 of 172

Recommended Authors

Collaborators

Memorial Sloan Kettering Cancer Center
Co-authored papers 51
Memorial Sloan Kettering Cancer Center
Co-authored papers 19
Co-authored papers 19
Memorial Sloan Kettering Cancer Center
Co-authored papers 17
Broad Institute of MIT and Harvard
Co-authored papers 12
Memorial Sloan Kettering Cancer Center
Co-authored papers 12
Memorial Sloan Kettering Cancer Center
Co-authored papers 10
Co-authored papers 10
The Center for Stem Cell Biology, Memorial Sloan Kettering Cancer Center
Co-authored papers 9
Memorial Sloan Kettering Cancer Center
Co-authored papers 8
Feil Family Brain and Mind Research Institute.
Co-authored papers 8
Co-authored papers 7
Memorial Sloan Kettering Cancer Center
Co-authored papers 7
Memorial Sloan Kettering Cancer Center
Co-authored papers 6
Memorial Sloan Kettering Cancer Center
Co-authored papers 6
Memorial Sloan-Kettering Cancer Center
Co-authored papers 5
Cleveland Clinic.
Co-authored papers 5
Co-authored papers 5
University of Massachusetts Medical School
Co-authored papers 4
Institucio Catalana de Recerca i Estudis Avancats (ICREA)
Co-authored papers 4
Co-authored papers 4
Co-authored papers 4
Memorial Sloan Kettering Cancer Center
Co-authored papers 4
Co-authored papers 4
Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center
Co-authored papers 4
Co-authored papers 4
Co-authored papers 4
Memorial Sloan Kettering Cancer Center
Co-authored papers 4
Co-authored papers 4
Co-authored papers 4